tiprankstipranks
Trending News
More News >
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858)
:1858
Hong Kong Market

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has a market cap or net worth of HK$6.47B. The enterprise value is HK$4.45B.
Market CapHK$6.47B
Enterprise ValueHK$4.45B

Share Statistics

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has 95,140,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding95,140,500
Owned by Insiders
Owned by Institutions

Financial Efficiency

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 4.24%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.24%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee651.46K
Profits Per Employee101.04K
Employee Count1,237
Asset Turnover0.23
Inventory Turnover0.53

Valuation Ratios

The current PE Ratio of Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H is 24.31. Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s PEG ratio is -1.26.
PE Ratio24.31
PS Ratio0.00
PB Ratio1.99
Price to Fair Value1.08
Price to FCF335.68
Price to Operating Cash Flow131.82
PEG Ratio-1.26

Income Statement

In the last 12 months, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H had revenue of 805.86M and earned 124.99M in profits. Earnings per share was 0.33.
Revenue805.86M
Gross Profit516.49M
Operating Income130.71M
Pretax Income131.60M
Net Income124.99M
EBITDA169.32M
Earnings Per Share (EPS)0.33

Cash Flow

In the last 12 months, operating cash flow was -1.90M and capital expenditures -49.17M, giving a free cash flow of -51.07M billion.
Operating Cash Flow-1.90M
Free Cash Flow-51.07M
Free Cash Flow per Share-0.54

Dividends & Yields

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pays an annual dividend of HK$0.052, resulting in a dividend yield of 3.27%
Dividend Per ShareHK$0.052
Dividend Yield3.27%
Payout Ratio75.64%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.17
52-Week Price Change27.96%
50-Day Moving Average9.89
200-Day Moving Average8.64
Relative Strength Index (RSI)65.18
Average Volume (3m)1.44M

Important Dates

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend DateJun 30, 2025

Financial Position

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H as a current ratio of 5.20, with Debt / Equity ratio of 0.05%
Current Ratio5.20
Quick Ratio4.19
Debt to Market Cap0.00
Net Debt to EBITDA-6.73
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has paid 6.94M in taxes.
Income Tax6.94M
Effective Tax Rate0.05

Enterprise Valuation

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H EV to EBITDA ratio is 11.22, with an EV/FCF ratio of -37.18.
EV to Sales2.36
EV to EBITDA11.22
EV to Free Cash Flow-37.18
EV to Operating Cash Flow-999.69

Balance Sheet

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has HK$1.89B in cash and marketable securities with ¥866.44K in debt, giving a net cash position of -HK$1.88B billion.
Cash & Marketable SecuritiesHK$1.89B
Total Debt¥866.44K
Net Cash-HK$1.88B
Net Cash Per Share-HK$19.81
Tangible Book Value Per ShareHK$7.11

Margins

Gross margin is 76.03%, with operating margin of 16.22%, and net profit margin of 15.51%.
Gross Margin76.03%
Operating Margin16.22%
Pretax Margin16.33%
Net Profit Margin15.51%
EBITDA Margin21.01%
EBIT Margin16.34%

Analyst Forecast

The average price target for Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-32.05%
EPS Growth Forecast-54.47%

Scores

Smart Score6
AI Score65
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis